T1	CHEM 14 22	aspirina
#1	AnnotatorNotes T1	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T2	DISO 44 82	síndrome de distrés respiratorio agudo
#2	AnnotatorNotes T2	C2887484; Acute respiratory distress syndrome in adult or child; Disease or Syndrome
T3	PROC 96 142	internados en la Unidad de Cuidados Intensivos
#3	AnnotatorNotes T3	C5419131; Intensive Care Unit Stay; Health Care Activity
T4	CHEM 242 250	aspirina
#4	AnnotatorNotes T4	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T5	DISO 287 291	SDRA
#5	AnnotatorNotes T5	C2887484; Acute respiratory distress syndrome in adult or child; Disease or Syndrome
T6	PROC 329 389	ensayo clínico experimental, prospectivo aleatorizado simple
#6	AnnotatorNotes T6	C0678323; experimentation; Research Activity + C0033522; Prospective Studies; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T7	PROC 652 671	de manera aleatoria
#7	AnnotatorNotes T7	C0034656; Randomization; Research Activity
T8	PROC 548 567	ingresaron a la UCI
#8	AnnotatorNotes T8	C5419131; Intensive Care Unit Stay; Health Care Activity
T9	PROC 602 613	diagnóstico
#9	AnnotatorNotes T9	C0011900; Diagnosis; Diagnostic Procedure
T10	DISO 617 621	SDRA
#10	AnnotatorNotes T10	C2887484; Acute respiratory distress syndrome in adult or child; Disease or Syndrome
T11	CHEM 714 722	aspirina
#11	AnnotatorNotes T11	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T12	PROC 734 754	tratamiento estándar
#12	AnnotatorNotes T12	C2936643; Standard of Care; Health Care Activity
T13	DISO 760 764	SDRA
#13	AnnotatorNotes T13	C2887484; Acute respiratory distress syndrome in adult or child; Disease or Syndrome
T14	PROC 791 818	tratamiento médico estándar
#14	AnnotatorNotes T14	C2936643; Standard of Care; Health Care Activity
T15	DISO 824 828	SDRA
#15	AnnotatorNotes T15	C2887484; Acute respiratory distress syndrome in adult or child; Disease or Syndrome
T16	PROC 866 886	valores de PaO2/FiO2
#16	AnnotatorNotes T16	C3897988; Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement; Laboratory Procedure
T17	PROC 892 909	valores de DA-aO2
T18	PROC 930 950	ventilación mecánica
#17	AnnotatorNotes T18	C0199470; Mechanical ventilation; Therapeutic or Preventive Procedure
T19	PROC 1341 1361	ventilación mecánica
#18	AnnotatorNotes T19	C0199470; Mechanical ventilation; Therapeutic or Preventive Procedure
T20	CHEM 1570 1578	aspirina
#19	AnnotatorNotes T20	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T21	DISO 1596 1600	SDRA
#20	AnnotatorNotes T21	C2887484; Acute respiratory distress syndrome in adult or child; Disease or Syndrome
T22	PROC 1813 1822	PaO2/FiO2
#21	AnnotatorNotes T22	C3897988; Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement; Laboratory Procedure
T23	PROC 1778 1798	ventilación mecánica
#22	AnnotatorNotes T23	C0199470; Mechanical ventilation; Therapeutic or Preventive Procedure
T24	PROC 1272 1281	PaO2/FiO2
#23	AnnotatorNotes T24	C3897988; Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement; Laboratory Procedure
T25	LIVB 86 95	pacientes
#24	AnnotatorNotes T25	C0030705; Patients; Patient or Disabled Group
T26	Duration 262 269	28 días
T27	LIVB 273 282	pacientes
#25	AnnotatorNotes T27	C0030705; Patients; Patient or Disabled Group
T28	Date 425 445	01 diciembre de 2015
T29	Date 449 468	30 de junio de 2016
T30	LIVB 534 543	pacientes
#26	AnnotatorNotes T30	C0030705; Patients; Patient or Disabled Group
T31	Dose 704 710	100 mg
T33	Duration 1365 1374	15.8 días
T35	LIVB 1582 1591	pacientes
#27	AnnotatorNotes T35	C0030705; Patients; Patient or Disabled Group
T40	PHYS 64 76	respiratorio
#28	AnnotatorNotes T40	C0035203; Respiration; Physiologic Function
T32	Duration 1382 1386	16.8
#29	AnnotatorNotes T32	[Duration expressed in days]
T41	PROC 1445 1463	estancia en la UCI
#30	AnnotatorNotes T41	C5419131; Intensive Care Unit Stay; Health Care Activity
T34	PROC 1699 1717	estancia en la UCI
#31	AnnotatorNotes T34	C5419131; Intensive Care Unit Stay; Health Care Activity
T36	Neg_cue 1649 1651	no
T37	Observation 1652 1675	disminuye la mortalidad
A1	Assertion T37 Negated
R1	Negation Arg1:T36 Arg2:T37	
T38	Neg_cue 1493 1495	no
T39	CONC 1501 1511	diferencia
A2	Assertion T39 Negated
R2	Negation Arg1:T38 Arg2:T39	
T42	Neg_cue 1220 1222	No
T43	CONC 1236 1246	diferencia
A3	Assertion T43 Negated
R3	Negation Arg1:T42 Arg2:T43	
T44	Neg_cue 1751 1758	tampoco
T45	CONC 1759 1765	reduce
A4	Assertion T45 Negated
R4	Negation Arg1:T44 Arg2:T45	
#32	AnnotatorNotes T43	C1705241; Delta (difference); Quantitative Concept
#33	AnnotatorNotes T39	C1705241; Delta (difference); Quantitative Concept
T46	Neg_cue 1800 1802	ni
T47	Observation 1803 1809	mejora
A5	Assertion T47 Negated
#34	AnnotatorNotes T47	C0184511; Improved; Finding (?)
R5	Negation Arg1:T46 Arg2:T47	
T48	Observation 1 7	Efecto
#35	AnnotatorNotes T48	C1518681; Outcome of Therapy; Finding (?)
R6	Causes Arg1:T1 Arg2:T48	
T49	CONC 29 39	mortalidad
#36	AnnotatorNotes T49	C0085556; Hospital Mortality; Qualitative Concept
R7	Experiences Arg1:T25 Arg2:T2	
R9	Experiences Arg1:T25 Arg2:T1	
R10	Experiences Arg1:T25 Arg2:T48	
R11	Experiences Arg1:T25 Arg2:T3	
T50	Observation 199 205	efecto
#37	AnnotatorNotes T50	C1518681; Outcome of Therapy; Finding (?)
T51	Observation 212 227	morbimortalidad
R13	Experiences Arg1:T27 Arg2:T50	
R14	Causes Arg1:T4 Arg2:T50	
R15	Experiences Arg1:T27 Arg2:T4	
R16	Experiences Arg1:T27 Arg2:T51	
R17	After Arg1:T50 Arg2:T26	
R18	Experiences Arg1:T27 Arg2:T5	
R19	After Arg1:T6 Arg2:T28	
R20	Before Arg1:T6 Arg2:T29	
R21	Experiences Arg1:T30 Arg2:T8	
R23	Before Arg1:T8 Arg2:T7	
R24	Experiences Arg1:T30 Arg2:T10	
R25	Has_Dose_or_Strength Arg1:T11 Arg2:T31	
R26	Combined_with Arg1:T11 Arg2:T12	
T52	Observation 915 920	Cstat
#38	AnnotatorNotes T52	C0429681; Static lung compliance; Finding
T53	Observation 1838 1843	Cstat
#39	AnnotatorNotes T53	C0429681; Static lung compliance; Finding
T54	Observation 903 909	DA-aO2
#40	AnnotatorNotes T54	C0429685; Alveolar-arterial oxygen tension difference; Finding
T55	Observation 994 1009	score APACHE II
#41	AnnotatorNotes T55	C0489438; APACHE II score; Finding
T56	Observation 1031 1046	morbimortalidad
T57	PROC 892 899;912 920	valores de Cstat
R27	Overlap Arg1:T16 Arg2:T18	
R28	Overlap Arg1:T57 Arg2:T18	
R32	Overlap Arg1:T17 Arg2:T55	
R34	Overlap Arg1:T57 Arg2:T55	
T58	CONC 1078 1109	prueba estadística T de Student
#42	AnnotatorNotes T58	C0871453; Students T Test; Intellectual Product
T59	CONC 1158 1168	mortalidad
#43	AnnotatorNotes T59	C0085556; Hospital Mortality; Qualitative Concept
R36	Has_Duration_or_Interval Arg1:T19 Arg2:T33	
R37	Has_Duration_or_Interval Arg1:T19 Arg2:T32	
T60	CONC 1466 1492	estancia intrahospitalaria
#44	AnnotatorNotes T60	C3489408; Hospital Stay; Temporal Concept | C0420512; Inpatient stay; Functional Concept
T61	Quantifier_or_Qualifier 1512 1542	estadísticamente significativa
A6	Assertion T61 Negated
#45	AnnotatorNotes T61	C0237881; Statistical Significance; Quantitative Concept
R38	Has_Quantifier_or_Qualifier Arg1:T39 Arg2:T61	
R39	Experiences Arg1:T35 Arg2:T20	
R40	Experiences Arg1:T35 Arg2:T21	
T62	Quantifier_or_Qualifier 1601 1612	establecido
#46	AnnotatorNotes T62	C0443211; Established; Qualitative Concept
R41	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T62	
R48	Before Arg1:T20 Arg2:T37	
R49	Before Arg1:T21 Arg2:T37	
T63	CONC 1723 1744	estancia hospitalaria
#47	AnnotatorNotes T63	C3489408; Hospital Stay; Temporal Concept | C0420512; Inpatient stay; Functional Concept
R52	Overlap Arg1:T19 Arg2:T41	
R53	Overlap Arg1:T19 Arg2:T60	
R56	Overlap Arg1:T34 Arg2:T23	
R59	Experiences Arg1:T35 Arg2:T23	
R60	Experiences Arg1:T35 Arg2:T34	
R61	Experiences Arg1:T35 Arg2:T22	
R62	Experiences Arg1:T35 Arg2:T53	
T64	Observation 1827 1832	DAaO2
#48	AnnotatorNotes T64	C0429685; Alveolar-arterial oxygen tension difference; Finding
R63	Experiences Arg1:T35 Arg2:T64	
R68	Overlap Arg1:T23 Arg2:T22	
R69	Overlap Arg1:T23 Arg2:T64	
R70	Overlap Arg1:T23 Arg2:T53	
R71	Overlap Arg1:T34 Arg2:T22	
R72	Overlap Arg1:T34 Arg2:T64	
R73	Overlap Arg1:T34 Arg2:T53	
R74	Negation Arg1:T38 Arg2:T61	
#49	AnnotatorNotes T45	C0547047; Decrease; Functional Concept
R8	Overlap Arg1:T17 Arg2:T18	
R12	Overlap Arg1:T16 Arg2:T55	
T65	Neg_cue 1677 1679	ni
T66	CONC 1680 1695	acorta los días
A7	Assertion T66 Negated
R22	Negation Arg1:T65 Arg2:T66	
#50	AnnotatorNotes T17	C3203470; Alveolar-arterial oxygen gradient; Laboratory Procedure (?)
A8	Experiencer T25 Patient
A9	Experiencer T27 Patient
A10	Experiencer T30 Patient
A11	Experiencer T35 Patient
